European Union · Question · QUESTION_WRITTEN
E-9-2020-004458
Cost of remdesivir/Veklury contract with Gilead Sciences
Introduced
30 July 2020
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 October 2020
Official titles
Authentic titles published by the source. The stored canonical title is not replaced.
1 official language
French
Coût du contrat avec Gilead Sciences relatif au remdesivir/Veklury
Records
Official question E-9-2020-004458 from European Union at European Parliament. Dated 30 July 2020. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Cost of remdesivir/Veklury contract with Gilead Sciences
QUESTION_WRITTEN · EN · 25 August 2020
Cost of remdesivir/Veklury contract with Gilead Sciences
QUESTION_WRITTEN · EN · 25 August 2020
Cost of remdesivir/Veklury contract with Gilead Sciences
QUESTION_WRITTEN · EN · 25 August 2020
Answer
QUESTION_WRITTEN_ANSWER · 21 October 2020
Coût du contrat avec Gilead Sciences relatif au remdesivir/Veklury
QUESTION_WRITTEN · FR · 25 August 2020
Coût du contrat avec Gilead Sciences relatif au remdesivir/Veklury
QUESTION_WRITTEN · FR · 25 August 2020
Coût du contrat avec Gilead Sciences relatif au remdesivir/Veklury
QUESTION_WRITTEN · FR · 25 August 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.